Skip to main content
Advertisement
Advertisement
VOGX
VOGX logo
Vogenx Inc Common Stock
19.26
USD
Sponsored
+0.92
+5.02%
Nov 10, 15:59 UTC -5
Closed
exchange

After-Market

19.07

-0.20
-1.01%

Vogenx Inc Common Stock (VOGX) Profile

Vogenx Inc Common Stock Profile

About

Vogenx Inc. is a clinical-stage biopharmaceutical company. It focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including PBH and gastroparesis. The company's product candidate includes mizagliflozin, is an orally administered, minimally absorbed small molecule drug candidate in development for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome. Vogenx Inc. is based in RALEIGH, NC.

Info & Links

CEO

James Green

Headquarters

3901 BARRETT DRIVE, SUITE 300
RALEIGH, NC 27609, UNITED STATES

Sector

Medical

Auditor

BDO USA, P.C.

Share holders

--

Employees

--

Vogenx Inc Common Stock Statistics

Valuation Measures

Market Capitalization2

283.21M

Enterprise Value

278.09M

Enterprise Value/EBITDA(ttm)

-130.06

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

21.61%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-2.14M

Net Income Available to Common(ttm)

-5.29M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

--

52-Week Change

--

S&P 500 52-Week Change

16.37%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

14.86M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

82.12M

Total Cash Per Share(mrq)

5.53

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

-48.77%

Current Ratio(mrq)

0.44%

Quick Ratio(mrq)

0.44%

Book Value Per Share(mrq)

-0.34

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.06

Free Cash Flow(ytd)

-323.10K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement